NCT05977751
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
FINALE: Prospective Multi-Center Trial for FemBloc INtratubal Occlusion for TranscervicAL PErmanent Birth Control
Femasys Inc.·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Contraception
- Drug/Device/Intervention
- FemBloc
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Femasys Inc.
- Location
- Columbus,Cincinnati, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Aug 01, 2023
- End date
- Jun 01, 2031
- Enrollment
- 573 participants
Primary outcome
Pregnancy Rate
Summary
Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing
 FemBloc followed by ultrasound confirmation test.
ICD-10 classifications
Contraceptive managementOral contraceptivesOther contraceptive managementGeneral counselling and advice on contraceptionPersonal history of contraception
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05977751
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT05977751 through Pure Global AI's free database. This phase not specified trial is sponsored by Femasys Inc. and is currently Recruiting. The study focuses on Contraception. Target enrollment is 573 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.